We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Siemens Healthineers Demonstrates Power of Data with Atellica Diagnostics IT Solutions

By LabMedica International staff writers
Posted on 05 Aug 2019
Print article
Image: The Atellica Diagnostics IT portfolio is helping labs manage increasing workloads, staffing challenges, and decreasing budgets with innovative data-driven solutions (Photo courtesy of Siemens Healthineers).
Image: The Atellica Diagnostics IT portfolio is helping labs manage increasing workloads, staffing challenges, and decreasing budgets with innovative data-driven solutions (Photo courtesy of Siemens Healthineers).
Siemens Healthineers (Erlangen, Germany) demonstrated the power of leveraging data to unlock a laboratory’s full potential by showcasing its Atellica Diagnostics IT portfolio at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo. At AACC 2019, the company featured its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing.

The Siemens Healthineers Atellica Diagnostics IT portfolio enables laboratories to unlock their full potential by leveraging data to optimize workflows. With easy-to-navigate user interfaces and centralized management of operations, the robust software solution enhances visibility into valuable business analytics that unify sample, process, result, and inventory data. These features have enabled laboratories to achieve a 93% reduction in testing errors, an 85% increase in patient and staff satisfaction, and an 88% achievement rate for 30-minute STAT turnaround.

The Atellica portfolio pipeline includes the Atellica Asa Application, a tablet-based virtual assistant designed to simplify and organize operator interactions with the instruments. The goal of the Atellica Asa Application is to draw staff attention to a single interface with only the most common, yet critical, procedures needed to complete daily system operations. The tile-based software is designed to organize operator tasks by workflow and to reduce the number of screens used to complete a single task.

In addition to demonstrations of the Atellica Asa virtual assistant, attendees learned more about LifeNet, an online program that helps labs increase system utilization by providing a centralized platform to schedule system maintenance and view service history of connected Siemens Healthineers systems. Attendees also explored the artificial intelligence-driven Guardian Program, which can help to predict certain system failures up to 21 days before they happen. By monitoring more than 80 critical components in real time, the Guardian Program can continuously detect potential issues and schedule repairs at a time that will not affect turnaround time, maintaining workflow during peak hours. Visitors to the Siemens Healthineers booth also experienced their own virtual reality journey through a simulated hospital environment to visualize in vitro testing and workflow possibilities based upon tailored needs.

Additionally, Siemens Healthineers unveiled its newest technology for point-of-care testing—the RAPIDPoint 500e Blood Gas System—for product demonstration at the event.

“Point-of-care testing enables clinicians to deliver the right test in the right setting for their patients at the right time,” said Christoph Pedain, PhD, Head of Point-of-Care Diagnostics, Siemens Healthineers.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Nutating Mixer
Enduro MiniMix

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.